Global Urolithiasis Management Devices Market is expected to grow at a significant CAGR in the upcoming years as the scope, product types, and its applications are increasing across the globe. Urolithiasis is a communal disorder that affects the global population. Urolithiasis is the growth of kidney stones in the urinary system. Urinary stones are normally distinguished based on the chemical composition, and location. Based on chemical composition, these are characterized into uric acid, calcium, and oxalate stones. It comprises nephrolithiasis (growth of kidney stones), cystolithiasis (stone formation in the bladder), ureterolithiasis (stone formation in ureters).
Urolithiasis Management Devices Market is categorized based on product type, applications, and geography. Urolithiasis Management Devices Industry is categorized based on product types such as Extracorporeal Shock Wave Lithotripsy (Eswl), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatments. Urolithiasis Management Devices Market is categorized based on application into Hospitals & Clinics, Ambulatory Surgical Centers
Urolithiasis Management Devices Market is categorized based on geography into Asia Pacific (China, India, ASEAN, Australia & New Zealand), Japan, Middle East and Africa (GCC countries, S. Africa, Rest Of MEA), North America (U.S., Canada), Latin America (Brazil, Rest of Latin America), Western Europe (Germany, Italy, France, England, Spain, Rest of Western Europe), and Eastern Europe (Poland, Russia, Rest of Eastern Europe). North America has been at the forefront with regards to Urolithiasis Management Devices Industry and will continue to rule the roost in the years to come.
Some of the key players that fuel the growth of the Urolithiasis Management Devices Market include DirexGroup, Richard Wolf, Karl Storz GmbH & Co. KG, Inc., Cook Medical, Siemens Healthcare, Boston Scientific Corporation, Dornier MedTech GmbH, C.R. Bard, ConMed Corporation, Allengers Medical Systems Ltd., Guangzhou Potent Optotronic Technology Co., Ltd., HealthTronics, Inc. The key players are focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Urolithiasis Management Devices in these regions, from 2013 to 2025 (forecast), covering
• North America
• Southeast Asia
Global Urolithiasis Management Devices market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Allengers Medical Systems Ltd.
• Boston Scientific Corporation
• C.R. Bard, Inc.
• Cook Medical
• ConMed Corporation
• Dornier MedTech GmbH
• Guangzhou Potent Optotronic Technology Co., Ltd.
• HealthTronics, Inc.
• Karl Storz GmbH & Co. KG
• Olympus Corporation
• Richard Wolf
• Siemens Healthcare
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Extracorporeal Shock Wave Lithotripsy (Eswl)
• Intracorporeal Lithotripsy
• Percutaneous Nephrolithotomy
• Other Treatments
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• Hospitals & Clinics
• Ambulatory Surgical Centers
Research Support Specialist, USA